GlassScriptPhysician profile
Michael Dinizo
NPI 1316393184
$14,954.54
in general payments reported to CMS, 2019-2025
32 companies · $2,486 in 2025
The $2,486 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $3,149 · 2023: $2,855 · 2024: $6,303 · 2025: $2,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,165 · Food and Beverage: $5,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,165.11 |
| Food and Beverage | $5,478.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,302.97 | 2023-2025 | Other - Miscellaneous, Lif, Invictus Mis |
| Stryker Corporation | $2,160.87 | 2022-2024 | Everest Spinal System, Tritanium, Ozark Cervical Plate System |
| Seapearl East, INC | $1,926.71 | 2023-2025 | |
| Globus Medical, INC. | $1,218.63 | 2022-2025 | Senza, Alif Instruments (Universal) |
| Nuvasive, INC. | $1,075.47 | 2022-2023 | Acp, Tlif |
| Arthrex, INC. | $1,032.70 | 2024 | |
| Medtronic, INC. | $554.30 | 2021-2022 | |
| Providence Medical Technology, INC. | $427.63 | 2024-2025 | |
| Djo, LLC | $287.62 | 2023-2024 | Cmf |
| Intrinsic Therapeutics | $248.11 | 2024 | Barricaid Acd (Annular Closure Device) |
| Spineart USA INC | $198.46 | 2024 | |
| Orthofix Medical, INC. | $156.50 | 2023-2024 | Trinity Elite, Physio-Stim |
| Cerapedics INC. | $150.87 | 2022 | |
| 4web, INC. | $146.58 | 2022 | |
| Depuy Synthes Sales INC. | $136.14 | 2024 | Teligen |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Royal Biologics, INC. | $130.00 | 2024 | |
| Zimmer Biomet Holdings, INC. | $125.05 | 2022 | |
| Si-Bone, INC. | $112.04 | 2022-2023 | |
| Lifenet Health | $84.27 | 2025 | Graftlink |
| Centinel Spine, LLC | $80.20 | 2022 | |
| Zimvie INC. | $60.85 | 2022-2023 | |
| Nalu Medical, INC. | $60.14 | 2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $60.02 | 2024 | Eterna |
| Bioventus LLC | $57.95 | 2023-2025 | Xcell, Durolane, Bonescalpel |
| Asensus Surgical, INC. | $44.81 | 2024 | Senhance |
| Precision Medical Products INC. | $25.16 | 2024 | Xstim Spinal Fusion Stimulator |
| Highridge Medical LLC | $17.45 | 2024 | Biomet Ebi Bone Healing System |
| International Rehabilitative Sciences, INC | $15.95 | 2024 | Rs 4i Plus Sequential Stimulator |
| Kci USA, INC. | $15.75 | 2022 | |
| Fidia Pharma USA INC. | $13.82 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.80 | 2023 | Seglentis |
| Vericel Corporation | $13.72 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dinizo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.